Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Mounjaro™ (tirzepatide) – New drug approval
May 13, 2022 - The FDA announced the approval of Eli Lilly’s Mounjaro (tirzepatide), as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).
